Details of the Drug
General Information of Drug (ID: DMQIFJ9)
Drug Name |
2-Furan-2-yl-4,5-dihydro-1H-imidazole
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-Furan-2-yl-4,5-dihydro-1H-imidazole; 2-(furan-2-yl)-4,5-dihydro-1H-imidazole; 40029-93-4; CHEMBL14410; 2-(2-furyl)-4,5-dihydro-1H-imidazole; AC1LHNFC; BAS 00087895; 2-(2-furyl)imidazoline; 2-(2-imidazolin-2-yl)furan; 2-(1-Imidazoline-2-yl)furan; CTK5J7407; DTXSID40357040; MolPort-001-914-212; HMS1698J05; ZINC4992560; BDBM50138501; 2536AE; AKOS000301450; MCULE-8474767921; ST072486; TR-043590
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 136.15 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 0.3 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||
References